Nathan Littlejohn

University of Arkansas for Medical Sciences

Papers

3

Total Citations

56

H-Index

2

About

Nathan Littlejohn is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in the management of testicular and kidney cancers. His most significant contribution is in the challenging domain of post-chemotherapy robotic retroperitoneal lymph node dissection (PC-RRPLND), a procedure for removing residual masses after chemotherapy for testicular cancer. His 2015 study, cited 47 times, provided critical early evidence that robotic surgery is a safe and effective option in this difficult setting, helping to expand the role of robotics beyond primary surgeries. Littlejohn has also made notable strides in pediatric urology, demonstrating in a 2016 study that robotic pyeloplasty can be performed faster than traditional laparoscopic approaches for treating ureteropelvic junction obstruction in children. Additionally, his work on partial nephrectomy in overweight patients addresses the growing need for tailored surgical strategies in a complex patient population. Through these contributions, Littlejohn has helped refine surgical standards, reduce operative times, and broaden the application of robotic technology in urologic oncology and pediatric care.

Research Focus

Key Achievements

2
H-Index
3
Papers
56
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience
47 citations · 2015
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Arkansas for Medical Sciences

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago